Overexpression of IGF-1 in Muscle Attenuates Disease in a Mouse Model of Spinal and Bulbar Muscular Atrophy

This publication has 53 references indexed in Scilit:

• Spinal and bulbar muscular atrophy: a motoneuron or muscle disease?
  Current Opinion in Pharmacology, 2008
• Subcutaneous IGF-1 is not beneficial in 2-year ALS trial
  Neurology, 2008
• In vivo suppression of polyglutamine neurotoxicity by C-terminus of Hsp70-interacting protein (CHIP) supports an aggregation model of pathogenesis
  Neurobiology of Disease, 2008
• Ablation of the UPR-Mediator CHOP Restores Motor Function and Reduces Demyelination in Charcot-Marie-Tooth 1B Mice
  Neuron, 2008
• Overexpression of wild-type androgen receptor in muscle recapitulates polyglutamine disease
  Proceedings of the National Academy of Sciences, 2007
• Androgen-dependent pathology demonstrates myopathic contribution to the Kennedy disease phenotype in a mouse knock-in model
  Journal of Clinical Investigation, 2006
• Androgen-dependent pathology demonstrates myopathic contribution to the Kennedy disease phenotype in a mouse knock-in model
  Journal of Clinical Investigation, 2006
• Pathogenesis, animal models and therapeutics in Spinal and bulbar muscular atrophy (SBMA)
  Experimental Neurology, 2006
• Protein aggregation and neurodegenerative disease
  Nature Medicine, 2004
• The IGF-1/PI3K/Akt Pathway Prevents Expression of Muscle Atrophy-Induced Ubiquitin Ligases by Inhibiting FOXO Transcription Factors
  Molecular Cell, 2004